Skip to menu Skip to content Skip to footer
  • UQ Home
  • Contacts
  • Study
  • Maps
  • News
  • Events
  • Library
  • Give now
  • my.UQ
The University of Queensland
Institute for Molecular Bioscience Institute for Molecular Bioscience
Site search
Site search
Menu
  • Home
  • About
    • Our people
    • News and Features
      • Latest news
    • Major supporters
    • Governance
    • Diversity and Inclusion
    • Annual reports
    • Careers
    • Women in science
  • Research
    • Research Leaders
    • Research Groups
    • Research Centres
    • Research Excellence
    • Research Impact
    • Research Community
  • Facilities
    • Microscopy
    • Mass Spectrometry
    • Queensland Facility for Advanced Genome Editing
    • Queensland Facility for Advanced Bioinformatics (QFAB)
    • Queensland Emory Drug Discovery Initiative
    • Clive & Vera Ramaciotti Facility for Producing Pharmaceuticals in Plants
    • Centre for Solar Biotechnology Facility
    • Sequencing facility
  • Partner
  • Students
    • Why IMB
    • PhD
    • Masters by Research (MPhil)
    • Masters by Coursework
    • Honours
    • Undergraduate
    • Scholarships
    • Visiting Research Scholars
  • Get Involved
    • Events
    • Support our research
    • Philanthropy in action
    • 21st Anniversary
    • The Edge magazine
    • Talks & Tours
    • Scientific artwork
    • Citizen Science
    • Ambassadors
    • The Director's Circle
    • The Edge: Conversations
  • Give now
  • Contact

Understanding pain pathways

Our facilities & services

The Vetter group uses whole cell patch-clamp electrophysiology, automated electrophysiology, high-content and high-throughput imaging of dissociated sensory neurons as well as transiently or stably transfected mammalian cell lines to assess pharmacological effects on a range of ligand- and voltage-gated ion channels as well as G protein-coupled receptors. Her group routinely perform high-content screening and pharmacological characterisation of compounds from a range of sources and have established a state-of-the-art behavioural facility and single fiber extracellular recording setup at the University of Queensland for translational to preclinical models.

Research projects

To investigate the neuropharmacology of pain we use a range of techniques including: in vivo pain pathway characterisation, high-content imaging of cultured sensory neurons, high-throughput screening using calcium and membrane potential assays, and traditional pharmacological assays. While all pain has similar symptoms, it is becoming clear that the underlying mechanisms behind pain can vary.

By uncovering these new pain pathways, as well as identifying novel targets on peripheral sensory neurons, we aim to develop more effective pain therapies that treat the underlying cause of the pain, not just the symptoms.

 

Traineeships, honours and PhD projects

We always have a range of research projects available for volunteers, undergraduate and postgraduate students. If you are interested, please contact A/Prof Vetter.

  • Discovery and development of novel analgesic venom peptides
  • Pharmacological characterisation of sensory neurons
  • Discovery and characterisation of ion channels and regulatory proteins
  • Discovery and characterisation of pain mechanisms in a range of diseases
  • Fundamental basis of peripheral sensory perception
  • Identifying and characterising the effect of venoms and toxins on peripheral sensory neurons
  • Identifying, characterising and optimising molecules with therapeutic potential from natural sources
  • Understanding the pathophysiology of pain and optimising analgesic treatment approaches. 

Publications

  • Neurotoxic peptides from the venom of the giant Australian stinging tree.

    Gilding EK, Jami S, Deuis JR, Israel MR, Harvey PJ, Poth AG, Rehm FBH, Stow JL, Robinson SD, Yap K, Brown DL, Hamilton BR, Andersson D, Craik DJ, Vetter I, Durek T.Sci Adv. 2020 Sep 16;6(38):eabb8828. 

View all Publications 

Partnerships and collaborations

A/Prof Vetter works in collaboration with other leading Australian and international researchers and welcomes new collaborations. Together with leading peptide chemists, molecular biologists, electrophysiologists, clinicians, NMR and structural biology experts, the Vetter group seeks to unravel the molecular and structural basis of nociception.

Our past and present collaborators span a network of world-class researchers with complementary skill sets that further strengthen our capacity to conduct the highest quality research and produce outstanding research outcomes. Our collaborators are the best in the world in their respective fields, including mathematics, biophysics, membrane interactions, structure determination, modelling, transcriptomics, ion channel pharmacology, chemistry, pain management and ex vivo sensory recordings.

© The University of Queensland
Enquiries: +61 7 3365 1111   |   Contact directory
ABN: 63 942 912 684   |   CRICOS Provider No: 00025B
Emergency
Phone: 3365 3333
Privacy & Terms of use   |   Feedback   |   Updated: 17 Dec 2020
Login